BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36111831)

  • 1. Clinical features and prognostic implications of ecotropic viral integration site 1 (
    Jia M; Hu BF; Zhang JY; Xu LY; Tang YM
    Pediatr Hematol Oncol; 2023 May; 40(4):371-381. PubMed ID: 36111831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adverse impact of ecotropic viral integration site-1 (EVI1) overexpression on the prognosis of acute myeloid leukemia with KMT2A gene rearrangement in different risk stratification subtypes.
    Liu XX; Pan XA; Gao MG; Kong J; Jiang H; Chang YJ; Zhang XH; Wang Y; Liu KY; Chen Z; Zhao XS; Huang XJ
    Int J Lab Hematol; 2023 Apr; 45(2):195-203. PubMed ID: 36358022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low EVI1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients.
    Yang L; Dao FT; Lu AD; Chen WM; Li LD; Long LY; Liu YR; Liu KY; Zhang LP; Qin YZ
    Pediatr Hematol Oncol; 2022 Mar; 39(2):97-107. PubMed ID: 34156313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis.
    Wu X; Wang H; Deng J; Zheng X; Ling Y; Gong Y
    Ann Hematol; 2019 Nov; 98(11):2485-2496. PubMed ID: 31482295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving Chemotherapy.
    Qin YZ; Zhao T; Zhu HH; Wang J; Jia JS; Lai YY; Zhao XS; Shi HX; Liu YR; Jiang H; Huang XJ; Jiang Q
    Med Sci Monit; 2018 Feb; 24():758-767. PubMed ID: 29408852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal time-points for detecting expression levels of BAALC, EVI1, and WT1 genes in patients with acute myeloid leukemia: a meta-analysis.
    Yuen KY; Lin XY; Zhou YZ; Luo H; Liu Y; Xu LH
    Hematology; 2021 Dec; 26(1):995-1006. PubMed ID: 34871539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High
    Zheng Y; Huang Y; Le S; Zheng H; Hua X; Chen Z; Feng X; Li C; Zheng M; Xu H; He Y; He X; Li J; Hu J
    Front Oncol; 2021; 11():712747. PubMed ID: 34589425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
    Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
    [No Abstract]   [Full Text] [Related]  

  • 9. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
    Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
    J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia.
    Su G; Lian X; Tan D; Tao H; Liu H; Chen S; Yin H; Wu D; Yin B
    Leuk Lymphoma; 2015 Feb; 56(2):472-9. PubMed ID: 24828867
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Elsherif M; Hammad M; Hafez H; Yassin D; Ashraf M; Yasser N; Lehmann L; Elhaddad A
    Acta Oncol; 2022 Apr; 61(4):516-522. PubMed ID: 35038958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group.
    Ho PA; Alonzo TA; Gerbing RB; Pollard JA; Hirsch B; Raimondi SC; Cooper T; Gamis AS; Meshinchi S
    Br J Haematol; 2013 Sep; 162(5):670-7. PubMed ID: 23826732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic Significance of Joint Detection of miR-210 and Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia].
    Mei YY; Li ZG; Zhang Y; Zhang WL; Zhang PW; Wang N; Huang DS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):66-71. PubMed ID: 28245377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.
    Lugthart S; van Drunen E; van Norden Y; van Hoven A; Erpelinck CA; Valk PJ; Beverloo HB; Löwenberg B; Delwel R
    Blood; 2008 Apr; 111(8):4329-37. PubMed ID: 18272813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.
    Haas K; Kundi M; Sperr WR; Esterbauer H; Ludwig WD; Ratei R; Koller E; Gruener H; Sauerland C; Fonatsch C; Valent P; Wieser R
    Genes Chromosomes Cancer; 2008 Apr; 47(4):288-98. PubMed ID: 18181178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and biological characteristics of childhood acute myeloid leukemia with EVI1 gene positive expression].
    Jiang M; Li XQ; Hu D; Qiu YN; Zhang ZQ; Zhang BY; Han J; Jin RM
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):129-34. PubMed ID: 24568904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Report of Chinese Children's Cancer Group acute lymphoblastic leukemia 2015 multicenter study].
    Chinese Children′s Cancer Group Acute Lymphoblastic Leukemia 2015 Study Group
    Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1002-1010. PubMed ID: 36207846
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
    Li XY; Li JQ; Luo XQ; Wu XD; Sun X; Xu HG; Li CG; Liu RY; Sun XF; Chen HQ; Lin YD; Li CK; Fang JP
    BMC Cancer; 2021 Jan; 21(1):59. PubMed ID: 33435902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
    Jia M; Hu BF; Xu XJ; Zhang JY; Li SS; Tang YM
    Curr Probl Cancer; 2021 Dec; 45(6):100758. PubMed ID: 34034913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.
    Conter V; Bartram CR; Valsecchi MG; Schrauder A; Panzer-Grümayer R; Möricke A; Aricò M; Zimmermann M; Mann G; De Rossi G; Stanulla M; Locatelli F; Basso G; Niggli F; Barisone E; Henze G; Ludwig WD; Haas OA; Cazzaniga G; Koehler R; Silvestri D; Bradtke J; Parasole R; Beier R; van Dongen JJ; Biondi A; Schrappe M
    Blood; 2010 Apr; 115(16):3206-14. PubMed ID: 20154213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.